ZHAO Jing-jing, XU Tong, ZHOU Yi
赵泾泾综述, 徐通, 周翊审校
|  Polanczyk GV, Willcutt EG, Salum GA, et al. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis[J]. Epidemiol,2014,43(2):434-442.
 Bron T,Bijlenga D,Verduijn J. Prevalence of ADHD symptoms across clinical stages of major depressive disorder[J].J Affect Disord, 2016,197(1):29-35.
 Adamo N, Seth S, Coghill D. Pharmacological treatment of attention-deficit hyperactivity disorder: assessing outcomes[J]. Expert Rev Clin Pharmacol, 2015,8(4):383-397.
 VelöS, Keresztény A, Szentiványi D,et al. Quality of life of patients with attention-deficit/hyperactivity disorder: systematic review of the past 5 years[J]. Neuropsychopharmacol Hung, 2013,15(2):73-82.
 Montoya A, Quai D,Anand E,et al. Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention deficit/hyperactivity disorder, based on a pooled analysis[J]. ADHD Atten Def Hyp Disord, 2014, 6(1):25-34.
 Coghill D,Banaschewski T,Soutullo C. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder[J]. Eur Child Adolesc Psychiatry,2017,26(11):1283-1307.
 Schei J, Novik TS, Thomsen PH, et al. Improved quality of life among adolescents with attention-deficit/hyperactivity disorder is mediated by protective factors: a cross sectional survey[J]. BMC Psychiatry, 2015, 15:108.
 Marques JC, Oliveira JA,Goulardins JB, et al. Comparison of child self-reports and parent proxy-reports on quality of life of children with attention deficit hyperactivity disorder[J]. Health Qual Life Outcomes, 2013, 11:186.
 Coghill D,Hodgkins P. Health-related quality of life of children with attention-deficit hyperactivity disorder versus children with diabetes and healthy controls[J]. Eur Child Adolesc Psychiatry,2016,25(3):261-271.
 Wehmeier PM, Schacht A, Dittmann RW, et al. Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder[J]. Qual Life Res, 2011, 20(5):691-702.
 Danckaerts M,Sonuga-Barke EJS,Banaschewski T,et al. The quality of life of children with attention deficit hyperactivity disorder:a systematic review[J]. Eur Child Adolesc Psychiatry, 2010,19(2):83-105.
 Banaschewski T, Johnson M, Lecendreux M, et al. Health-related quality of life and functional outcomes from a randomized withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder[J]. CNS Drugs, 2014,28(12):1191-1203.
 Dell′Agnello G, Maschietto D, Bravaccio C, et al. Atomoxetine hydrochloride in the treatment of children and adolescents with attention deficit hyperactivity disorder and comorbid oppositional defiant disorder:a placebo-controlled Italian study[J]. Eur Neuropsychopharmacol, 2009,19(11):822-834
 CoghillD.The impact of medications on quality of life in attention-deficit hyperactivity[J]. CNS Drugs, 2010, 24 (10): 843-866.
 Berek M, Kordon A, Hargarter L, et al.. Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS® MPH: is treatment response different between children and adolescents?[J]. Child Adolesc Psychiatry Men Health, 2011, 5:26.
 Hodgkins P, Shaw M, McCarthy S. The pharmacology and clinical outcomes of amphetamines to treat ADHD:does composition Matter?[J]. CNS Drugs, 2012, 26 (3): 245-268.
 Yang P, Hsu HY, Chiou SS, et al. Health-related quality of life in methylphenidate-treated children with attention deficit-hyperactivity disorder: results from a Taiwanese sample[J]. Aust NZJ Psychiatry,2007, 41(12):998-1004
 Wehmeier PM, Schacht A, Escobar R, et al.Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and attention deficit/hyperactivity disorder core symptoms: META-analysis of five atomoxetine trials[J]. Child Adolesc Psychiatry Ment Health, 2010, 4:30
 Savill NC,Buitelaar JK, Anand E,et al. The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder:A comprehensive review of over a decade of clinical research[J]. CNS Drugs, 2015, 29(2):131-151.
 Escobar R,Schacht A,Wehmeier P, et al. Quality of life and attention deficit hyperactivity disorder core symptoms[J]. J Clin Psychopharmacol, 2010,30(2),145-151.
 Prasad S,Harpin V, Poole L, et al. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)[J]. Curr Med Res Opin, 2007,23(2):379-394.
 Haynes H. Attention-deficit/hyperactivity disorder under treatment outcomes research (AUTOR): a European observational study in pediatric subjects ADHD[J].Atten Def Hyp Disord, 2015, 7(4):295-311.
 Cannon M, Pelham WH, Sallee FR, et al. Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder[J]. Child and Adolescent Psychopharmacology, 2009,19(5):511-517.
|||XIANG Wei. Early prevention of dyslipidemia in children and adolescents as well as cardiovascular health in adulthood [J]. Chinese Journal of Child Health Care, 2023, 31(7): 697-702.|
|||WU Ting, LI Fei. Adverse factors in early life and the development and prevention of chronic diseases [J]. Chinese Journal of Child Health Care, 2023, 31(7): 703-706.|
|||LIU Haodong, LI Cheng, ZHAO Min, XI Bo. Association of abdominal obesity and pre-abdominal obesity with hyperuricemia in children [J]. Chinese Journal of Child Health Care, 2023, 31(7): 707-712.|
|||LIU Min, ZHANG Qian, YANG Ting, CHEN Jie, CHEN Li, DAI Ying, JIA Feiyong, WU Lijie, HAO Yan, LI Ling, ZHANG Jie, KE Xiaoyan, YI Mingji, HONG Qi, CHEN Jinjin, FANG Shuanfeng, WANG Yichao, WANG Qi, JIN Chunhua, LI Tingyu. Multi-center survey on serum folic acid in preschool children in China [J]. Chinese Journal of Child Health Care, 2023, 31(7): 713-717.|
|||HUO Yanyan, LIU Zhongling, MA Ling, WU Dan, WANG Xiulian, QIU Xiaoyan, DOU Jiaying, REN Yuqian, LI Yicheng, HONG Xia, CHEN Jinjin. Status quo and risk factors for different body proportions of children under 2 years old in the real world [J]. Chinese Journal of Child Health Care, 2023, 31(7): 718-723.|
|||LIU Huijuan, SONG Zhixiao, GAO Nannan, ZHANG Li, SUN Jin, QIAO Xiuyun, KE Jiamei, LI Yan. Status quo and related factors of Chinese vocabulary and grammar development in children aged 2 to 6 years [J]. Chinese Journal of Child Health Care, 2023, 31(7): 724-730.|
|||LI Rong, LI Nian, WU Dandan, HUANG Rong, CHEN Yinhua. Effect of methylphenidate hydrochloride prolonged-release tablets on the growth of children with attention deficit hyperactivity disorder [J]. Chinese Journal of Child Health Care, 2023, 31(7): 731-735.|
|||ZHANG Chao. Application of early start Denver model in the rehabilitation of children with autism spectrum disorder of different conditions [J]. Chinese Journal of Child Health Care, 2023, 31(7): 736-740.|
|||YANG Yuru, WANG Hong, XU Shuhong, CAO Yanmei, MENG Xian, GE Dongmei. Association between bone development and vitamin K in children aged 0 to 14 years [J]. Chinese Journal of Child Health Care, 2023, 31(7): 746-750.|
|||YE Zhixu, YU Fuxun. Research progress of gut microbiota and respiratory virus infection in children [J]. Chinese Journal of Child Health Care, 2023, 31(7): 766-769.|
|||LI Weiwei, ZHANG Dandan, LIU Xiaoming, CHEN Jiao, XIA Lu. Application of long-term management mode based on Internet technology in children with intractable epilepsy [J]. Chinese Journal of Child Health Care, 2023, 31(7): 781-784.|
|||ZHU Lijun, LI Biaozhang, ZHOU Jiawen, WU Baixin, LI Weidong. Disease burden of low body weight in children under 5 years old in China from 1990 to 2019 [J]. Chinese Journal of Child Health Care, 2023, 31(7): 790-793.|
|||CAO Yachuan, DOU Jijuan, MA Yaping, REN Jindong, CHEN Xinyan. Correlation of lipid metabolism with left ventricular hypertrophy and left ventricular remodeling in obese children [J]. Chinese Journal of Child Health Care, 2023, 31(7): 809-812.|
|||LI Xiuhong. Early identification of Chinese developmental dyslexia should be valued [J]. Chinese Journal of Child Health Care, 2023, 31(6): 586-589.|
|||WANG Hongan, YU Dongchuan, LIU Fulin, CHI Xia. Feasibility study on rapid screening of learning disabilities by number cancellation test in combination with machine learning algorithm [J]. Chinese Journal of Child Health Care, 2023, 31(6): 595-600.|